PL3484502T3 - Frakcje osocza krwi jako terapia związanych ze starzeniem zaburzeń funkcji poznawczych - Google Patents
Frakcje osocza krwi jako terapia związanych ze starzeniem zaburzeń funkcji poznawczychInfo
- Publication number
- PL3484502T3 PL3484502T3 PL17841780T PL17841780T PL3484502T3 PL 3484502 T3 PL3484502 T3 PL 3484502T3 PL 17841780 T PL17841780 T PL 17841780T PL 17841780 T PL17841780 T PL 17841780T PL 3484502 T3 PL3484502 T3 PL 3484502T3
- Authority
- PL
- Poland
- Prior art keywords
- aging
- treatment
- blood plasma
- cognitive disorders
- plasma fractions
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title 1
- 230000002431 foraging effect Effects 0.000 title 1
- 210000002381 plasma Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376529P | 2016-08-18 | 2016-08-18 | |
| US201662412258P | 2016-10-24 | 2016-10-24 | |
| PCT/US2017/029953 WO2018034712A1 (en) | 2016-08-18 | 2017-04-27 | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| EP17841780.4A EP3484502B1 (en) | 2016-08-18 | 2017-04-27 | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3484502T3 true PL3484502T3 (pl) | 2022-01-31 |
Family
ID=61196950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17841780T PL3484502T3 (pl) | 2016-08-18 | 2017-04-27 | Frakcje osocza krwi jako terapia związanych ze starzeniem zaburzeń funkcji poznawczych |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20190321449A1 (ru) |
| EP (2) | EP3484502B1 (ru) |
| JP (3) | JP7316931B2 (ru) |
| KR (3) | KR20190032614A (ru) |
| CN (2) | CN109963582B (ru) |
| AU (3) | AU2017312722B2 (ru) |
| BR (1) | BR112019003172A2 (ru) |
| CA (1) | CA3033051A1 (ru) |
| CL (1) | CL2019000304A1 (ru) |
| CY (1) | CY1124695T1 (ru) |
| DK (1) | DK3484502T3 (ru) |
| ES (1) | ES2899147T3 (ru) |
| HR (1) | HRP20211628T1 (ru) |
| HU (1) | HUE056294T2 (ru) |
| IL (2) | IL264660B2 (ru) |
| LT (1) | LT3484502T (ru) |
| MA (1) | MA45692B1 (ru) |
| MD (1) | MD3484502T2 (ru) |
| MX (1) | MX2019001718A (ru) |
| NZ (1) | NZ750885A (ru) |
| PL (1) | PL3484502T3 (ru) |
| PT (1) | PT3484502T (ru) |
| RS (1) | RS62558B1 (ru) |
| SG (1) | SG11201901273TA (ru) |
| SI (1) | SI3484502T1 (ru) |
| UA (1) | UA126232C2 (ru) |
| WO (1) | WO2018034712A1 (ru) |
| ZA (1) | ZA202004834B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10357513B2 (en) * | 2017-04-26 | 2019-07-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| CA3097083A1 (en) | 2018-05-15 | 2019-11-21 | Alkahest, Inc. | Treatment of aging-associated disease with modulators of leukotriene a4 hydrolase |
| CN110724176B (zh) * | 2018-07-16 | 2021-10-26 | 北京豪思生物科技有限公司 | 一种治疗阿尔茨海默症的血浆蛋白分离物及其制备方法和应用 |
| CN110787187B (zh) * | 2018-07-16 | 2022-05-13 | 北京豪思生物科技股份有限公司 | 一种增强记忆力和提高认知功能的血浆混合物及其制备方法和应用 |
| CA3105956A1 (en) * | 2018-07-20 | 2020-01-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| IL282227B1 (en) * | 2018-10-26 | 2024-04-01 | Alkahest Inc | Use of plasma and plasma fractions to improve pain, wound healing and recovery after surgery |
| CN110448686B (zh) * | 2019-09-19 | 2022-11-04 | 北京豪思生物科技股份有限公司 | 铜蓝蛋白联合运铁蛋白的应用 |
| US20220362293A1 (en) * | 2019-09-25 | 2022-11-17 | Cytegen Corp. | Treatment of Mitochondrial Deficits and Age-Related Diseases Using Blood Products |
| US11439687B2 (en) | 2019-11-04 | 2022-09-13 | Alkahest, Inc. | Blood plasma fractions for use in muscle regeneration |
| CA3156906A1 (en) | 2019-11-20 | 2021-05-27 | Alkahest, Inc. | Blood plasma fractions for use in liver regeneration |
| US11484551B2 (en) | 2019-11-20 | 2022-11-01 | Alkahest, Inc. | Method of treating liver failure with plasma fraction IV-4 |
| AU2022376563A1 (en) | 2021-11-01 | 2023-12-07 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
| WO2024102244A1 (en) * | 2022-11-11 | 2024-05-16 | Alkahest, Inc. | Blood plasma fractions for improvement of myelination |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3869431A (en) | 1973-03-12 | 1975-03-04 | Firestone Tire & Rubber Co | Polyamides and their production |
| US4624780A (en) | 1982-06-28 | 1986-11-25 | Alpha Therapeutic Corporation | Fractionation of blood plasma |
| DE3612137A1 (de) * | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
| US5138034A (en) * | 1989-07-12 | 1992-08-11 | The Green Cross Corporation | Method of fractionating plasma proteins |
| US5110907A (en) | 1989-08-01 | 1992-05-05 | Alpha Therapeutic Corporation | Factor viii complex purification using heparin affinity chromatography |
| US5288853A (en) | 1992-04-30 | 1994-02-22 | Alpha Therapeutic Corporation | Factor viii purification process |
| US5219995A (en) | 1992-07-14 | 1993-06-15 | Alpha Therapeutic Corporation | Plasma fraction purification |
| US5561115A (en) * | 1994-08-10 | 1996-10-01 | Bayer Corporation | Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
| JP4402885B2 (ja) * | 2001-05-11 | 2010-01-20 | 財団法人化学及血清療法研究所 | 新規な神経変性疾患治療剤 |
| US20070010435A1 (en) * | 2002-12-19 | 2007-01-11 | New York University | Method for treating amyloid disease |
| US20040146565A1 (en) * | 2003-01-28 | 2004-07-29 | Lauridsen Group Incorporated | First lipoprotein fraction and therapeutic compositions of same |
| US20130121979A1 (en) * | 2003-12-29 | 2013-05-16 | Allan Mishra | Method of treating cancer using platelet compositions |
| ES2257225B1 (es) | 2006-02-17 | 2007-03-16 | Grifols, S.A | Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion. |
| ES2332846B1 (es) * | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| AU2009236305B2 (en) | 2008-04-15 | 2014-04-10 | Grifols Therapeutics Inc. | Two-stage ultrafiltration/diafiltration |
| US20090297485A1 (en) | 2008-05-28 | 2009-12-03 | Allan Mishra | Compositions and methods for treating psychiatric and neurodegenerative disorders |
| AU2013203043B2 (en) * | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| EP3552624A1 (en) * | 2013-05-06 | 2019-10-16 | Baxalta Incorporated | Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g |
| JP6667438B2 (ja) | 2013-12-09 | 2020-03-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 老化に関連する状態を処置する方法及び組成物 |
| ES2524516B1 (es) | 2014-05-29 | 2015-03-31 | Grifols Worldwide Operations Limited | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
| EA039316B1 (ru) * | 2016-10-24 | 2022-01-12 | Алкахест, Инк. | Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением |
| US10357513B2 (en) * | 2017-04-26 | 2019-07-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11040068B2 (en) * | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
-
2017
- 2017-04-27 AU AU2017312722A patent/AU2017312722B2/en active Active
- 2017-04-27 PT PT178417804T patent/PT3484502T/pt unknown
- 2017-04-27 CA CA3033051A patent/CA3033051A1/en active Pending
- 2017-04-27 MA MA45692A patent/MA45692B1/fr unknown
- 2017-04-27 LT LTEPPCT/US2017/029953T patent/LT3484502T/lt unknown
- 2017-04-27 IL IL264660A patent/IL264660B2/en unknown
- 2017-04-27 WO PCT/US2017/029953 patent/WO2018034712A1/en unknown
- 2017-04-27 HR HRP20211628TT patent/HRP20211628T1/hr unknown
- 2017-04-27 MX MX2019001718A patent/MX2019001718A/es unknown
- 2017-04-27 CN CN201780057412.0A patent/CN109963582B/zh active Active
- 2017-04-27 SG SG11201901273TA patent/SG11201901273TA/en unknown
- 2017-04-27 HU HUE17841780A patent/HUE056294T2/hu unknown
- 2017-04-27 RS RS20211337A patent/RS62558B1/sr unknown
- 2017-04-27 EP EP17841780.4A patent/EP3484502B1/en active Active
- 2017-04-27 NZ NZ750885A patent/NZ750885A/en unknown
- 2017-04-27 DK DK17841780.4T patent/DK3484502T3/da active
- 2017-04-27 ES ES17841780T patent/ES2899147T3/es active Active
- 2017-04-27 SI SI201730964T patent/SI3484502T1/sl unknown
- 2017-04-27 KR KR1020197007543A patent/KR20190032614A/ko not_active IP Right Cessation
- 2017-04-27 UA UAA201901438A patent/UA126232C2/uk unknown
- 2017-04-27 IL IL304946A patent/IL304946A/en unknown
- 2017-04-27 PL PL17841780T patent/PL3484502T3/pl unknown
- 2017-04-27 KR KR1020227025297A patent/KR20220107322A/ko not_active IP Right Cessation
- 2017-04-27 EP EP21192528.4A patent/EP3995140A1/en active Pending
- 2017-04-27 KR KR1020247007926A patent/KR20240036720A/ko active Search and Examination
- 2017-04-27 JP JP2019508828A patent/JP7316931B2/ja active Active
- 2017-04-27 BR BR112019003172A patent/BR112019003172A2/pt not_active Application Discontinuation
- 2017-04-27 MD MDE20190622T patent/MD3484502T2/ro unknown
- 2017-04-27 CN CN202211658689.8A patent/CN115957309A/zh active Pending
-
2019
- 2019-02-05 CL CL2019000304A patent/CL2019000304A1/es unknown
- 2019-06-28 US US16/456,717 patent/US20190321449A1/en not_active Abandoned
-
2020
- 2020-01-09 AU AU2020200181A patent/AU2020200181B2/en active Active
- 2020-07-16 ZA ZA2020/04834A patent/ZA202004834B/en unknown
-
2021
- 2021-09-28 AU AU2021240142A patent/AU2021240142B2/en active Active
- 2021-11-05 CY CY20211100958T patent/CY1124695T1/el unknown
- 2021-12-15 JP JP2021203571A patent/JP7447069B2/ja active Active
-
2022
- 2022-01-24 US US17/582,974 patent/US20220152161A1/en active Pending
-
2023
- 2023-08-17 JP JP2023133021A patent/JP2023156459A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004834B (en) | Blood plasma fractions as a treatment for aging-associated cognitive disorders | |
| IL288712A (en) | Methods for treating abnormal movement disorders | |
| HK1258518A1 (zh) | 用於眼病的基因療法 | |
| SG11201608729RA (en) | Membrane-adherent self-assembled systems for treatment of ocular disorders | |
| HK1252996A1 (zh) | 用於治療癲癇的方法 | |
| EP3119911A4 (en) | Methods for treating neurological disorders | |
| IL267229A (en) | Methods of treating ocular disorders | |
| HK1257272A1 (zh) | 治療hiv的工具 | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| IL259381B (en) | Miravegron for the treatment of retinal diseases | |
| LT3903774T (lt) | N,n-bis-2-merkaptoetilizoftalamidas, skirtas neurodegeneracinių ligų gydymui | |
| ZA201707232B (en) | Treatment of a hydrocarbon component | |
| GB201616285D0 (en) | Plasma abatement | |
| GB201616286D0 (en) | Plasma abatement | |
| GB201602784D0 (en) | New treatment of CFTR-related disorders |